--- title: What is aesPlla®? description: aesPlla® --- [Skip to content](https://support.foxpharma.co.uk/en-gb/what-is-aesplla#main-content) English - United Kingdom Show submenu for translations [Contact Fox Pharma](https://support.foxpharma.co.uk/en-gb/kb-tickets/new?hsLang=en-gb) [Customer portal](https://support.foxpharma.co.uk/account?hsLang=en-gb) ![Fox Pharma logo](https://support.foxpharma.co.uk/hs-fs/hubfs/Fox%20Pharma%20Full%20Logo.png?width=250&height=30&name=Fox%20Pharma%20Full%20Logo.png) Open main navigation Close main navigation - English - United Kingdom Show submenu for translations - [Contact Fox Pharma](https://support.foxpharma.co.uk/en-gb/kb-tickets/new) - [Customer portal](https://support.foxpharma.co.uk/account) - [View Website](https://foxpharma.co.uk/) [View Website](https://foxpharma.co.uk/) This is a search field with an autosuggest feature attached. - There are no suggestions because the search field is empty. 1. [Support](https://support.foxpharma.co.uk/en-gb/?hsLang=en-gb) 2. [Product Information](https://support.foxpharma.co.uk/en-gb//product-information?hsLang=en-gb) 17 April 2025 # What is aesPlla®? ## aesPlla® is a PLLA injectable that provides a natural-looking solution to volume loss, utilising PLLA to stimulate collagen production for gradual volumisation and rejuvenation. aesPlla® is a PLLA injectable that provides a natural-looking solution to volume loss, utilising PLLA to stimulate collagen production for gradual volumisation and rejuvenation. The treatment is ideal for patients 30+ who are concerned with skin ageing, dermal deficiencies, laxity and areas prone to volume loss, such as the cheeks, temples, nasolabial and marionette lines. Treating facial volume loss using aesPlla® is a gradual process that requires 3-4 treatments, spaced four weeks apart, in order to achieve optimal volumisation. NB: Must have a certification in PLLA fillers to purchase aesPlla® **Shelf life:** 21 months **Box Contents:** One box of aesPlla® contains 1 vial of product, containing 365mg of powder (150mg of PLLA). Recommended Consumables: Recommended consumables: 18G sterile needle + 1/3ml syringe to withdraw. We recommend a 26G cannula or needle to inject. Reconstitute using sterile water. **Shop aesPlla®** [https://foxpharma.co.uk/product/aesplla/](https://foxpharma.co.uk/product/aesplla/) **Material Properties** [https://foxpharma.co.uk/material-properties-aesplla/](https://foxpharma.co.uk/material-properties-aesplla/) - [Product Information](https://support.foxpharma.co.uk/en-gb//product-information?hsLang=en-gb) - [Shipping Information](https://support.foxpharma.co.uk/en-gb//shipping-information?hsLang=en-gb) - [Payments and Promotions](https://support.foxpharma.co.uk/en-gb//payments-and-promotions?hsLang=en-gb) - [Order Queries](https://support.foxpharma.co.uk/en-gb//order-queries?hsLang=en-gb) - [Returns and Refunds](https://support.foxpharma.co.uk/en-gb//returns-and-refunds?hsLang=en-gb) [![Fox Pharma logo](https://support.foxpharma.co.uk/hs-fs/hubfs/Fox%20Pharma%20Full%20Logo.png?width=250&height=30&name=Fox%20Pharma%20Full%20Logo.png "Fox Pharma logo")](https://foxpharma.co.uk/) [mailto:email@email.com](mailto:email@email.com) Copyright © 2026, foxpharma.co.uk